Los Angeles, CA -- (SBWire) -- 02/17/2019 --A market research report is a perfect tool for digging deep into critical aspects of the global Peptide Therapeutics market and closely understanding factors that influence its growth. Our research analysts are experienced enough to provide you with the right information about the global Peptide Therapeutics market to help your business propel forward in the coming years. What makes us different from other market researchers is our high level of analysis that helps you to identify key opportunities available in the global Peptide Therapeutics market. The report provides every bit of information about the global Peptide Therapeutics market related to major market segments, vendor landscape, geographical growth, and other significant factors.
The global Peptide Therapeutics market is valued at 28500 million US$ in 2018 is expected to reach 41900 million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025.
We deliver market intelligence according to your requirements. This report can be customized as per your business needs. We meet client expectations with the help of our peerless pre-execution, execution, and post-execution engagement models. Our analysts offer quantified B2B research on market threats and opportunities. They also provide qualitative analysis of the global Peptide Therapeutics market.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/965455/global-peptide-therapeutics-market
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
In this report, we study the peptide-based drugs. In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018. Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
Major Key Manufacturers of Peptide Therapeutics Market are:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J
Peptidthe e Therapeutics market includes market size, segmentation data and geographical analysis of market growth trends, leading companies, and microeconomic information.
Major Classification as follows:
Injection
Oral
Other
Major Application as follows:
Cancer
Metabolic Disorders
Central Nervous System
Other
Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/settlement/pre/1c9af0d42f8abdb99b2eda5a427125eb,0,1,Global%20Peptide%20Therapeutics%20Market%20Sizes%202019
Regions Covered in the Global Peptide Therapeutics Market:
The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Few of the questions answered through the report
(1) How will the global Peptide Therapeutics market performance during the forecast period? What will be the market size in terms of value and volume?
(2) Which segment will drive the global Peptide Therapeutics market? Which regional market will show extensive growth in the future? What are the reasons?
(3) How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
(4) What are the key strategies adopted by players to sustain themselves in the global Peptide Therapeutics market?
(5) How will these strategies influence market growth and competition?
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
Peptide Therapeutics Market Will Cross 41900 Million US$ by 2025: QY Research, Inc.